Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
fintepla
ucb pharma s.a. - fenfluramine hydrochloride - epilepsies, myoclonic - antiepileptics, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
duokopt (joz) augndropar, lausn 20 mg/ml + 5 mg/ml
laboratoires thea s.a.s. - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20 mg/ml + 5 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
buprenorphine alvogen (buprenorphine ratiopharm) forðaplástur 5 míkróg/klst.
alvogen ehf. - buprenorphinum inn - forðaplástur - 5 míkróg/klst.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
buprenorphine alvogen (buprenorphine ratiopharm) forðaplástur 10 míkróg/klst.
alvogen ehf. - buprenorphinum inn - forðaplástur - 10 míkróg/klst.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
arzotilol (dorzolamid + timolol actavis) augndropar, lausn 20 mg/ml +5 mg/ml
teva b.v.* - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20 mg/ml +5 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
otimectin vet. eyrnahlaup 1 mg/g
le vet b.v.* - ivermectinum inn - eyrnahlaup - 1 mg/g
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
buprenorphine alvogen (buprenorphine ratiopharm) forðaplástur 20 míkróg/klst.
alvogen ehf. - buprenorphinum inn - forðaplástur - 20 míkróg/klst.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
ceftriaxona normon innrennslisstofn, lausn 2000 mg
laboratorios normon, s.a. - ceftriaxonum dínatríum - innrennslisstofn, lausn - 2000 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
cosopt sine augndropar, lausn 20 mg/ml+5 mg/ml
santen oy* - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20 mg/ml+5 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
dorzolamide/timolol alvogen augndropar, lausn 20mg/ml+5 mg/ml
alvogen ehf. - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20mg/ml+5 mg/ml